Tibet Cheezheng Tibetan Medicine Co Ltd Class A 002287
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 22.25
- Day Range
- CNY 22.04–22.37
- 52-Week Range
- CNY 16.27–26.68
- Bid/Ask
- CNY 22.26 / CNY 22.27
- Market Cap
- CNY 11.81 Bil
- Volume/Avg
- 1.2 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 31.80
- Price/Sales
- 5.58
- Dividend Yield (Trailing)
- 1.75%
- Dividend Yield (Forward)
- 1.75%
- Total Yield
- 1.75%
Company Profile
Tibet Cheezheng Tibetan Medicine Co Ltd is Tibetan medicine manufacturer. It is mainly engaged in the research, development, production, and sales of Tibetan medicines. The company's products include medicines such as emplastrum, ointments, granules, pills, and powders.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 3,091
- Website
- http://www.cheezheng.com.cn
Comparables
Valuation
|
Metric
|
002287
|
600557
|
603896
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.80 | 21.28 | 23.00 |
Price/Book Value | 3.09 | 2.09 | 2.50 |
Price/Sales | 5.58 | 2.26 | 6.88 |
Price/Cash Flow | 17.27 | 8.48 | 19.25 |
Price/Earnings
002287
600557
603896
Financial Strength
|
Metric
|
002287
|
600557
|
603896
|
|---|---|---|---|
Quick Ratio | 2.14 | 2.19 | 3.29 |
Current Ratio | 2.28 | 2.52 | 3.64 |
Interest Coverage | 11.23 | — | 12.27 |
Quick Ratio
002287
600557
603896
Profitability
|
Metric
|
002287
|
600557
|
603896
|
|---|---|---|---|
Return on Assets (Normalized) | 6.17% | 7.20% | 7.77% |
Return on Equity (Normalized) | 11.00% | 9.86% | 11.42% |
Return on Invested Capital (Normalized) | 7.97% | 9.16% | 7.56% |
Return on Assets
002287
600557
603896
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hytgnbghg | Yfzm | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pxbtcryqw | Wzgjgn | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ycqwgnqb | Mmzxjb | $108.2 Bil | |
MRNA
| Moderna Inc | Khqzhjc | Qzwp | $50.9 Bil | |
ARGX
| argenx SE ADR | Ylgtbzng | Snst | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Krvtcfy | Kvpbz | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Wmgfdntp | Kqvkhqg | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Cmkvctxms | Czxdpq | $14.6 Bil | |
INCY
| Incyte Corp | Ycvjpvnm | Lscmvy | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nwtqzgnpgg | Hqmbz | $12.3 Bil |